A new drug developed by scientists at the National Institutes of Health limits the progression of liver fibrosis in mice, a hopeful advance against a condition for which there is no current treatment and that often leads to serious liver disease in people with chronic alcoholism and other common diseases.

“This study represents an important step towards an effective treatment for liver fibrosis,” said George F. Koob, Ph.D., director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of NIH. A report of the study, led by NIAAA scientists, is now online in JCI Insight.

Related posts:

  1. Supported studies show online course helps reduce harmful college drinking An online alcohol prevention course can help reduce harmful drinking among college freshmen, but the benefits in the fall don’t last through the spring, according to a study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health....
  2. NIH-supported mouse studies suggest treatment target for alcohol problems A molecular pathway within the brain’s reward circuitry appears to contribute to alcohol abuse, according to laboratory mouse research supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH). The findings, published online today in Proceedings of the National Academy of Sciences, also provide evidence that […]...
  3. Medicare Card, New drug for common liver disease improves liver health Medicare Card, New drug for common liver disease improves liver health...
  4. Study finds doctors miss many alcohol screening opportunities Physicians often fail to counsel their young adult patients about excessive alcohol use, according to a study led by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health....
  5. Medicare, Medicare Card, Receptor Variant Influences, Dopamine Response to Alcohol A genetic variant of a receptor in the brain’s reward circuitry plays an important role in determining whether the neurotransmitter dopamine is released in the brain following alcohol intake, according to a study led by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. Dopamine is […]...
  6. Study finds hospitalizations increase for alcohol and drug overdoses Hospitalizations for alcohol and drug overdoses — alone or in combination — increased dramatically among 18- to 24-year-olds between 1999 and 2008, according to a study by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health....
  7. Medicare Card, NIH study advances understanding of movement control Medicare Card, NIH study advances understanding of movement control...
  8. Medicare Card, NIH-supported study finds strategies to reduce college drinking Highly visible cooperative projects, in which colleges and their surrounding communities target off-campus drinking settings, can reduce harmful alcohol use among college students, according to a report by researchers supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health....
  9. Social media may help identify college drinking problems College students who post references to getting drunk, blacking out, or other aspects of dangerous drinking on social networking sites are more likely to have clinically significant alcohol problems than students who do not post such references, according to a study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the […]...
  10. Dr. Edward P. Riley to deliver 4th annual Jack Mendelson Honorary Lecture The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, announces that Edward P. Riley, Ph.D. will deliver the 4th annual Jack Mendelson Honorary Lecture. Riley is a world-renowned expert on Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Spectrum Disorders (FASD). His presentation is called “FASD: It’s What’s Behind […]...
  11. Medicare Card, NIH-developed candidate dengue vaccine shows promise in early-stage trial Medicare Card, NIH-developed candidate dengue vaccine shows promise in early-stage trial...
  12. Medicare Card, Study shows promise of precision medicine for most common type of lymphoma Medicare Card, Study shows promise of precision medicine for most common type of lymphoma...
  13. Medicare, Novel Therapeutic Approach, Shows Promise Against Multiple Bacterial Pathogens A team of scientists from government, academia and private industry has developed a novel treatment that protects mice from infection with the bacterium that causes tularemia, a highly infectious disease of rodents, sometimes transmitted to people, and also known as rabbit fever. In additional experiments with human immune cells, the treatment also demonstrated protection against […]...
  14. Medicare, Dr. Kenneth Kendler to deliver 17th Annual Mark Keller Honorary Lecture at NIH The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, announces that Kenneth Kendler, M.D. will deliver the 17th Annual Mark Keller Honorary Lecture. Kendler is a world-renowned expert on the genetics of psychiatric and substance abuse disorders. His presentation is called “The Genetic Epidemiology of Alcohol Use Disorders: […]...
  15. Commonly used three-drug regimen for idiopathic pulmonary fibrosis found harmful The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns....